JP2006518769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006518769A5 JP2006518769A5 JP2006507625A JP2006507625A JP2006518769A5 JP 2006518769 A5 JP2006518769 A5 JP 2006518769A5 JP 2006507625 A JP2006507625 A JP 2006507625A JP 2006507625 A JP2006507625 A JP 2006507625A JP 2006518769 A5 JP2006518769 A5 JP 2006518769A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- cyclodextrin
- amount
- hydroxypropyl
- edetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000243 solution Substances 0.000 claims 20
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 5
- 229920000858 Cyclodextrin Polymers 0.000 claims 3
- 239000001116 FEMA 4028 Substances 0.000 claims 3
- 229960004853 betadex Drugs 0.000 claims 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 2
- 229960005475 antiinfective agent Drugs 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 2
- 239000002738 chelating agent Substances 0.000 claims 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims 2
- 239000008139 complexing agent Substances 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 2
- 229960003957 dexamethasone Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229940054534 ophthalmic solution Drugs 0.000 claims 2
- 239000002997 ophthalmic solution Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 150000007660 quinolones Chemical class 0.000 claims 2
- 239000002294 steroidal antiinflammatory agent Substances 0.000 claims 2
- PCWPQSDFNIFUPO-VDQKLNDWSA-N (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-37,39,41,43,45,47,49-heptakis(2-hydroxyethoxy)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38,40,42,44,46,48-heptol Chemical compound OCCO[C@H]1[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](CO)[C@@H](O[C@H]1O[C@@H]2CO)[C@@H](O)[C@@H]8OCCO)[C@@H](O)[C@@H]7OCCO)[C@@H](O)[C@@H]6OCCO)[C@@H](O)[C@@H]5OCCO)[C@@H](O)[C@@H]4OCCO)[C@@H](O)[C@@H]3OCCO PCWPQSDFNIFUPO-VDQKLNDWSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 claims 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- 229960000686 benzalkonium chloride Drugs 0.000 claims 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical group [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960003405 ciprofloxacin Drugs 0.000 claims 1
- DIOIOSKKIYDRIQ-UHFFFAOYSA-N ciprofloxacin hydrochloride Chemical compound Cl.C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 DIOIOSKKIYDRIQ-UHFFFAOYSA-N 0.000 claims 1
- 229960001229 ciprofloxacin hydrochloride Drugs 0.000 claims 1
- 230000000536 complexating effect Effects 0.000 claims 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940009662 edetate Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229940037001 sodium edetate Drugs 0.000 claims 1
- 230000003637 steroidlike Effects 0.000 claims 1
- 229960005066 trisodium edetate Drugs 0.000 claims 1
- -1 β- cyclodextrin ethers Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN212MU2003 | 2003-02-21 | ||
| PCT/IN2004/000048 WO2004087043A2 (en) | 2003-02-21 | 2004-02-23 | Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006518769A JP2006518769A (ja) | 2006-08-17 |
| JP2006518769A5 true JP2006518769A5 (cg-RX-API-DMAC7.html) | 2007-04-12 |
Family
ID=33104995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006507625A Pending JP2006518769A (ja) | 2003-02-21 | 2004-02-23 | 安定な眼科用組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070148192A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1596823A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006518769A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050105477A (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0407583A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2516429A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05008913A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004087043A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5310590A (en) * | 1993-02-04 | 1994-05-10 | Minnesota Mining And Manufacturing Company | Stitchbonded articles |
| US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
| US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| DE602005011928D1 (de) | 2004-01-20 | 2009-02-05 | Allergan Inc | Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure |
| US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
| WO2006043965A1 (en) * | 2004-10-14 | 2006-04-27 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| AU2006270035A1 (en) * | 2005-07-15 | 2007-01-25 | Chakshu Research Inc. | Formulation and method for administration of ophthalmologically active agents |
| WO2007099431A2 (en) * | 2006-02-28 | 2007-09-07 | Wockhardt Ltd | An aqueous liquid pharmaceutical compositions of gatifloxacin |
| DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
| AU2016253668B2 (en) * | 2006-03-14 | 2018-12-06 | Cls Pharmaceuticals, Inc. | Ophthalmic compositions comprising povidone-iodine |
| US7767217B2 (en) | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| WO2008002117A1 (es) * | 2006-06-27 | 2008-01-03 | Jimenez Bayardo, Arturo | Solución oftálmica de ciprofloxacina y dexametasona |
| US9039761B2 (en) | 2006-08-04 | 2015-05-26 | Allergan, Inc. | Ocular implant delivery assemblies with distal caps |
| CN106038481A (zh) * | 2007-06-28 | 2016-10-26 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| CN101970042A (zh) | 2008-02-25 | 2011-02-09 | 眼门药品公司 | 经由离子电渗法增强递送治疗药物至眼部组织 |
| US20110117189A1 (en) * | 2008-07-08 | 2011-05-19 | S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. | Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
| EP2502616A1 (fr) * | 2011-03-21 | 2012-09-26 | Matthew Krayenbuhl | Composition pharmaceutique nasale |
| KR101304341B1 (ko) * | 2011-09-19 | 2013-09-11 | 한미약품 주식회사 | 코르티코스테로이드, 항히스타민제 및 β-사이클로덱스트린을 포함하는, 안정성이 개선된 약학 조성물 |
| US9504691B2 (en) * | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| CA3023243C (en) * | 2016-05-06 | 2020-01-21 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions and methods for fabricating thereof |
| PL3548091T3 (pl) * | 2016-11-29 | 2022-03-28 | Oculis SA | Otrzymywanie stałych kompleksów cyklodekstryny do dostarczenia czynnego składnika farmaceutycznego do oczu |
| CN113490691A (zh) | 2019-01-03 | 2021-10-08 | 劣势者药物有限公司 | 环糊精二聚体、其组合物及其用途 |
| DK3993807T3 (da) | 2019-07-01 | 2026-01-19 | Oculis Operations Sarl | Fremgangsmåde til stabilisering af ph-værden i en vandig sammensætning, der indeholder et lægemiddel |
| CN115461067A (zh) * | 2020-03-02 | 2022-12-09 | 法马马有限公司 | 用于炎症的化合物 |
| US20230233572A1 (en) * | 2020-06-11 | 2023-07-27 | Sentiss Pharma Private Limited | Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent |
| CN116531319A (zh) * | 2023-05-24 | 2023-08-04 | 德阳市人民医院 | 一种眼用抗菌凝胶及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3704907A1 (de) * | 1987-02-17 | 1988-08-25 | Bayer Ag | Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden |
| WO1990001933A1 (en) * | 1988-08-26 | 1990-03-08 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| JP2003510263A (ja) * | 1999-09-24 | 2003-03-18 | アルコン，インコーポレイテッド | シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物 |
| US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
| ATE424808T1 (de) * | 2000-11-15 | 2009-03-15 | Chandavarkar Mohan A | Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva |
-
2004
- 2004-02-23 EP EP04745101A patent/EP1596823A2/en not_active Withdrawn
- 2004-02-23 KR KR1020057015370A patent/KR20050105477A/ko not_active Withdrawn
- 2004-02-23 CA CA002516429A patent/CA2516429A1/en not_active Abandoned
- 2004-02-23 WO PCT/IN2004/000048 patent/WO2004087043A2/en not_active Ceased
- 2004-02-23 BR BRPI0407583-8A patent/BRPI0407583A/pt not_active IP Right Cessation
- 2004-02-23 US US10/546,417 patent/US20070148192A1/en not_active Abandoned
- 2004-02-23 JP JP2006507625A patent/JP2006518769A/ja active Pending
- 2004-02-23 MX MXPA05008913A patent/MXPA05008913A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006518769A5 (cg-RX-API-DMAC7.html) | ||
| WO2004087043B1 (en) | Stable ophthalmic formulation containing an antibiotic and a corticosteroid | |
| AU2009345790B2 (en) | Topical solution formulations containing a corticosteroid and a cyclodextrin | |
| JP2004532217A5 (cg-RX-API-DMAC7.html) | ||
| CA2444535A1 (en) | Formoterol/steroid bronchodilating compositions and methods of use thereof | |
| JP2002509101A (ja) | キレート化剤を含む、オートクレーブで処理できる医薬組成物 | |
| TW201206908A (en) | Pharmaceutical compositions and methods of making same | |
| JP2012520880A (ja) | ケトチフェンの眼科用製剤および使用方法 | |
| NZ541875A (en) | Intranasal formulation of rotigotine and cyclodextrin | |
| JP5864433B2 (ja) | カルボキシビニルポリマー含有ナノ粒子懸濁物 | |
| CA2540174A1 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| JP4674162B2 (ja) | アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤 | |
| JP2008024700A (ja) | ベルベリン含有水性組成物 | |
| BR112013016008B1 (pt) | Solução oftálmica compreendendo diquafosol, método para a produção da mesma, e método para a inibição da formação de precipitado insolúvel | |
| CN107073008A (zh) | 眼科用水性组合物 | |
| TWI406663B (zh) | 含有氟甲松龍之懸浮型點眼劑 | |
| CN102946855B (zh) | 含有妥布霉素和地塞米松的局部用眼科混悬剂 | |
| US20130251790A1 (en) | Low Dose Pharmaceutical Composition Comprising Zanamivir | |
| JP2005531528A5 (cg-RX-API-DMAC7.html) | ||
| JP3672342B2 (ja) | ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル | |
| JP2013529205A (ja) | 注射用イブプロフェン医薬組成物 | |
| JP2010518075A (ja) | 局所的鼻腔投与のためのオロパタジンの製剤 | |
| JP4754149B2 (ja) | 水性液剤 | |
| JP2011503142A5 (cg-RX-API-DMAC7.html) | ||
| CN100455286C (zh) | 帕洛诺司琼注射液及其制备方法 |